Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regeneration of ischemic cardiac damage using Wharton's jelly mesenchymal stem cells (CardioCell)
2016-004683-19Phase 2Completed
- Sponsor
- Krakowski Szpital Specjalistyczny im. Jana Pawła II
- Start
- Mar 2018
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial in ischaemic cardiomyopathy (ICM) comparing CardioCell with Placebo (2 arms). Started Mar 2018; status: completed.
02
Drugs
ischemia-tolerant mesenchymal stem cells
03
Conditions
ischaemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on 2016-004683-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004683-19.